SpaceX~$1TSpaceX~$1T
Insider Buying
Subscribe
All stock lists
DRTS

Alpha Tau Medical Ltd. (NASDAQ:DRTS)

IL · Delayed Price · Currency is USD
Healthcare · Biotechnology
13.01-0.15 (-1.17%)
 
Market cap
$1.20B
Analyst consensus
Listed since
Mar 8, 2021
Insider Score
––Not scored
DRTS Insider Score

Insiders filed in the last 90 days, but none of those trades qualified for scoring — round-trip buys and filings whose price is far off the market are excluded.

DRTS analyst forecast

DRTS analyst consensus

Moderate Buy2 ratings
Buy 2 Hold 0 Sell 0

Based on each firm’s most recent rating in the last 3 months — one vote per firm, so a desk that reiterates weekly does not count three times.

DRTS 12-month price target

$30.00+132.0% upsideaverage of 1 firm
$30.00High
$30.00Low

Best analysts covering DRTS

  • HC Wainwright & Co.55%success rate · 20 calls
  • Citigroup0%success rate · 1 call

Measured by us from each firm’s own rating dates and this stock’s split- and dividend-adjusted closes. How we calculate this.

DRTS analyst ratings

FirmPrice targetAction
—HC Wainwright & Co.Buy——Reiterated2026-10-20
BarclaysOverweight$30.00+109.4%Reiterated2026-09-03
—HC Wainwright & Co.Buy——Reiterated2026-08-11
—HC Wainwright & Co.Buy——Reiterated2026-07-22
—HC Wainwright & Co.Buy——Reiterated2026-07-16
—HC Wainwright & Co.Buy——Reiterated2026-06-04
—BarclaysOverweight——Reiterated2026-06-04
—HC Wainwright & Co.Buy——Reiterated2026-06-02
—HC Wainwright & Co.Buy——Reiterated2026-05-20
—Piper SandlerNeutral——Reiterated2026-05-19
—HC Wainwright & Co.Buy——Reiterated2026-05-12
—Ladenburg ThalmannBuy——Reiterated2026-05-12
—CitigroupBuy——Reiterated2026-03-11
—HC Wainwright & Co.Buy——Reiterated2026-03-10
—Piper SandlerNeutral——Downgraded2026-03-04
—HC Wainwright & Co.Buy——Reiterated2026-02-24
—CitigroupBuy——Reiterated2025-12-10
—HC Wainwright & Co.Buy——Reiterated2025-11-24
—HC Wainwright & Co.Buy——Reiterated2025-10-22
—HC Wainwright & Co.Buy——Reiterated2025-09-03
—HC Wainwright & Co.Buy——Reiterated2025-04-29
—HC Wainwright & Co.Buy——Reiterated2025-03-17
—HC Wainwright & Co.Buy——Reiterated2024-11-22
—HC Wainwright & Co.Buy——Reiterated2024-10-23
—HC Wainwright & Co.Buy——Reiterated2024-10-11
—HC Wainwright & Co.Buy——Reiterated2024-08-20
—Piper SandlerOverweight——Reiterated2024-08-15
—HC Wainwright & Co.Buy——Reiterated2024-06-26
—HC Wainwright & Co.Buy——Reiterated2024-05-22
—HC Wainwright & Co.Buy——Reiterated2024-05-16
—HC Wainwright & Co.Buy——Reiterated2024-03-12
—Piper SandlerOverweight——Reiterated2024-03-08
—HC Wainwright & Co.Buy——Reiterated2023-11-20
—Piper SandlerOverweight——Reiterated2023-11-17
—HC Wainwright & Co.Buy——Reiterated2023-09-20
—Cantor FitzgeraldOverweight——Reiterated2023-08-29
—HC Wainwright & Co.Buy——Reiterated2023-08-29
—HC Wainwright & Co.Buy——Reiterated2023-08-18
—HC Wainwright & Co.Buy——Reiterated2023-05-24
—HC Wainwright & Co.Buy——Reiterated2023-05-18
—HC Wainwright & Co.Buy——Reiterated2023-05-15
—HC Wainwright & Co.Buy——Reiterated2023-04-24
—Piper SandlerOverweight——Reiterated2022-11-23
—Cantor FitzgeraldOverweight——Reiterated2022-04-14
—Piper SandlerOverweight——Reiterated2022-04-08
—CitigroupBuy——Reiterated2022-04-04

DRTS earnings vs. estimates

QuarterEPS est.EPS actualRevenue est.Revenue actual
2026-03-09-0.13-0.14$63K$0
2026-05-18-0.13-0.26$50K$0
2026-08-10-0.14-0.50$145K$100K
2026-11-19-0.140.00$243K$0
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.